Related Experiment Videos
Oral ganciclovir as prophylaxis against cytomegalovirus
The New England Journal of Medicine
|October 31, 1996
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Bearing the burden of boat harbours: heavy contaminant and fouling loads in a native habitat-forming alga.
Marine pollution bulletin·2011
Treatment of vascular and soft-tissue sarcomas in dogs using an alternating protocol of ifosfamide and doxorubicin.
Veterinary and comparative oncology·2009
Intravenous administration of 9-aminocamptothecin to dogs with lymphoma.
Veterinary and comparative oncology·2009
Ertapenem versus cefepime for initial empirical treatment of pneumonia acquired in skilled-care facilities or in hospitals outside the intensive care unit.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology·2006
Catheter-Directed Thrombolysis in Intermediate-High-Risk Pulmonary Embolism.
The New England journal of medicine·2026
Timing of PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation.
The New England journal of medicine·2026
Pulmonary Denervation for Heart Failure-Related Pulmonary Hypertension.
The New England journal of medicine·2026
Targeted Use of Computed Tomographic Coronary Angiography in Acute Chest Pain.
The New England journal of medicine·2026
Complete Revascularization Guided by Functional Coronary Angiography in STEMI.
The New England journal of medicine·2026
Immediate Ambulatory Electrocardiographic Monitoring in Syncope.
The New England journal of medicine·2026
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026